Ask AI

CELMoDs in Myeloma—What’s Here, What’s Next, and What’s on the Horizon

Enhance your understanding of the mechanisms of action and differences in emerging CELMoDs used to manage multiple myeloma, and the clinical implications of achieving MRD negativity through a certified on-demand webcast, audio podcast, expert-authored ClinicalThought commentary, and downloadable slides.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb